Wednesday, April 29, 2015

Can Your Same Sex Marriage Be Validated By XQ28


Can Your Same Sex Marriage Be Validated By XQ28

Barron’s Medical Journal ---- B.Bobby Graham Reporting : ---- From Surpreme Court Washington DC -- USA < GlobeNewswire>< PRWire> < PRNewswire>


Same Sex Marriage -Changing Thousands Years Of Thinking In Only Ten Years :

Washington DC -- BMJPress -- The United States Supreme Court Is making a decision on Same Sex Marriage. The question is should we change thousands years of thinking after only considering about ten years of courts cases. At Barron Medical Journal we decided to look under the hood on this issue and investigate the science behind this matter. Barron’s research shows scientist have identified gene’s associated with being gay in males.

Some background on human genes and its DNA associations. A gene is a physical structure made from DNA. Genes function primarily by being expressed in the form of proteins. The conversion from gene to protein is a multistage process. First the gene is transcribed, making a RNA copy of itself that is then translated to create a protein. At least in men, homosexuality may be a function of genetics, according to a study of more than 400 pairs of gay brothers. The research, published in Psychological Medicine, confirms the role of a stretch of the X chromosome in determining sexual preference in men, a finding first suggested more than 20 years ago. The Supreme Court is giving indications to voting on this matter down party lines. The one Justice all stake holders are paying special attention to is Justice Kennedy. Justice Kennedy. He said he was concerned about changing a conception of marriage that has persisted for thousands of years based on little more than a decade of experience with same-sex marriage in the United States.

Brought To You By 2014 Cadillac ELR

“I don’t even know how to count the decimals when we talk about millennia,” he said. “This definition has been with us for millennia. And it’s very difficult for the court to say, ‘Oh, well, we know better.’ ” He added that “the social science on this” — the value and perils of same-sex marriage — is “too new.” Later, though, he expressed qualms about excluding gay couples from the institution of marriage. “Same-sex couples say, of course: ‘We understand the nobility and the sacredness of the marriage. We know we can’t procreate but we want the other attributes of it in order to show that we, too, have a dignity that can be fulfilled,’ ” Justice Kennedy said, strongly suggesting that the reasoning resonated with him.

Donald Pliner New Green Bottom Shoes Is The New Shoe Buzz

One of the leading scientist on the question of can our genes decided if we are gay or not is Dean Hamer. Dean is an American geneticist, author, and filmmaker. He is known for his contributions to biotechnology and AIDS prevention, his research on the genetics of human behavior. Dean study in 1993 proposed , Xq28, a region of the X chromosome, might play a role in determining whether a man was gay.

The X chromosome (Xq28) in sexual orientation by DNA linkage analyses of two newly ascertained series of families that contained either two gay brothers or two lesbian sisters as well as heterosexual siblings. Linkage between the Xq28 markers and sexual orientation was detected for the gay male families but not for the lesbian families or for families that failed to meet defined inclusion criteria for the study of sex−linked sexual orientation. Our results corroborate the previously reported linkage between Xq28 and male homosexuality in selected kinships and suggest that this region contains a locus that influences individual variations in sexual orientation in men but not in women.

Duplications in the telomeric neighboring regions, which include GDP dissociation inhibitor 1 gene (GDI1) and ras-associated protein RAB39B gene (RAB39B), are independently associated with ID, and many segmental duplications located in this region could mediate these frequently observed interstitial duplications.

The only question now is there going to be a company in the United States to lead in building tools to find answers to question such as, is there a gene or genes associated with being a gay male. One organization we found to be performing creditable research in this area is the The German cDNA Consortium.

Stefan Wiemann (DKFZ), H. Blöcker (GBF Braunschweig); A. Bahr (Qiagen GmbH Hilden); K. Köhrer (BMFZ Düsseldorf); W. Ansorge (EMBL Heidelberg); H.W. Mewes (GSF München); B. Ottenwälder (Medigenomix GmbH München); D. Heubner (AGOWA GmbH Berlin)

The German cDNA Consortium (see below) was formed in 1996 as the world's second large-scale cDNA analysis project, and aimed at systematically generating (Wellenreuther 2004), sequencing and annotating full-length cDNAs of human genes. The resources produced in this project have been our contribution to the ORFeome Collaboration and have substantially helped to reach comprehensive coverage of the human genes in that resource.

While gene identification was initially through EST-sequencing of cDNA libraries (we generated ESTs from ~250,000 cDNAs, and completely sequenced 15,000 full-length cDNAs), we later shifted towards the directed modelling of gene structures and the cloning of respective ORFs. The project was part of the National Genome Research Network (NGFN). We have adapted and routinely apply the Gateway cloning system (Invitrogen) for the cloning of protein coding regions (ORFs) (Simpson 2000, Bechtel 2007). This system is based on recombination and allows for the base specific and directional cloning of DNA. With a high level of automation we amplify the ORFs in a 2-step PCR process, adding 5' and 3' flanking Gateway compatible sites. Universal `entry clones´ are generated via recombination, they are compatible with any Gateway expression vector. The entry clones are completely sequence verified as an important step in the quality control process. Inserts of verified entry clones are recombined into a range of expression vectors. These constructs are utilised in functional profiling to determine the sub-cellular localisation of encoded proteins (-> LIFEdb) and to identify cellular effects of protein overexpression in cell-based functional assays (Wiemann 2004, Starkuviene 2004, Arlt 2005, Laketa 2007, Sauermann 2007). Based on these screens, a number of new functions and disease associations could be associated with respective hits (Neubrand 2005, Fleischer 2006, Sauermann 2008). Furthermore, the clone resource has been exploited in a number of collaborative projects (e.g.,Will 2010, Bai 2011, Lisauskas 2012, Simpson 2012, Walde 2012)

The sequence resources and expertise of the German cDNA Consortium have been basis of the systematic functional annotation of the human transcriptome, which has been carried out by the international H-invitational consortium (Imanishi 2004, Yamasaki 2008). The complete annotation is publicly available in the H-invitational database (http://www.h-invitational.jp/).

The winner in this area of clinical research is Genomics Science. Just a taught when you are choosing a major.

Tuesday, April 14, 2015

Barron’s Medical Journal Breast Cancer Person Of The Year “Jeanne Rizzo “ & A Cure Report


Barron’s Medical Journal ---- B.Bobby Graham Reporting : ---- From Rice University Houston, TX USA < GlobeNewswire>< PRWire> < PRNewswire>


Barron’s Medical Journal Breast Cancer Person Of The Year “Jeanne Rizzo “ & A Cure Report


Barron’s 10th Annual person of the year award for their contribution to breast cancer and A breast cancer cure is Jeanne Rizzo. Jeanne works for The Breast Cancer Fund and a breast cancer survivor.


Houston – ( AP ) -- Jeanne Rizzo’s vision guided the Breast Cancer Fund to adopt its bold mission to work to prevent breast cancer by eliminating our exposure to toxic chemicals and radiation linked to the disease. Under her direction the organization has become a national leader in translating the science linking breast cancer and environmental exposures into public education and advocacy campaigns that protect our health and reduce breast cancer risk.

Jeanne Rizzo President/CEO $ 173,580

Jeanne Rizzo’s vision guided the Breast Cancer Fund to adopt its bold mission of working to prevent breast cancer by eliminating exposure to toxic chemicals and radiation linked to the disease. Under her leadership the organization continues its commitment to strong science, smart public policy and consumer education. Ms. Rizzo co-chaired the National Institutes of Health’s Interagency Donald Pliner New Green Bottom Shoes Is The New Shoe Buzz Breast Cancer and Environmental Research Coordinating Committee, and is a recipient of the Environmental Protection Agency Region 9 Green Chemistry Environmental Leader Award. She is past chair of the California Breast Cancer Research Program Council and is a steering-committee member of the program’s Prevention Initiative. A nurse, then an award-winning music, theater and film producer, she produced the documentary Climb Against the Odds: Mt. McKinley, which chronicles the Breast Cancer Fund's 1998 expedition.

“when 1 in 8 women will be diagnosed with the disease, how much more awareness do we need? The Breast Cancer Fund is working to shift the conversation from awareness to prevention. We’re working to stop this disease before it starts, and we need the support of millions of people like you. You can start by pledging to go beyond the pink to prevention. “

In just a generation we’ve witnessed a 40-percent increase in breast cancer, and we know that environmental factors like toxic chemical exposures have played a major role. The Breast Cancer Fund is working to eliminate our exposure to toxic chemicals linked to the disease so that fewer of us, our daughters and increasingly our sons will ever have to hear the words, “You have breast cancer.”

Jeanne leads the organization’s strategic initiatives to remove the chemical bisphenol A, or BPA, from food packaging; to ensure cosmetics are non-toxic; and to overhaul the broken chemicals-management system that allows tens of thousands of toxic and untested chemicals to be used in consumer products. Recent legislative victories include the passage of a federal law banning toxic chemicals linked to breast cancer from toys, and California laws creating the first statewide biomonitoring program, advancing the safety of cosmetics and regulating chemicals in consumer products. Recent victories in the marketplace include a commitment from Campbell’s to remove BPA from its can linings and from Johnson & Johnson to globally reformulate its cosmetics products to remove harmful chemicals.

Breast Cancer Report Card Is A ( A ) ----- organizations like The Cancer Genome Atlas has made major advances in breast cancer research. Started in 2006 as a US $100-million pilot, The Cancer Genome Atlas (TCGA) is now the biggest component of the International Cancer Genome Consortium, a collaboration of scientists from 16 nations that has discovered nearly 10 million cancer-related mutations.

One of the best Research results is The Cancer Genome Atlas has identified four primary subtypes of breast cancer. Analyses of genomic data have confirmed that there are four primary subtypes of breast cancer, each with its own biology and survival outlooks. These TCGA findings are based on a large number of breast cancer specimens that capture a complete view of the genomic alterations. The four groups are called intrinsic subtypes of breast cancer: HER2-enriched (HER2E), Luminal A (LumA), Luminal B (LumB) and Basal-like. A fifth type, called Normal-like, was observed, but because of small numbers (only eight specimens) the researchers were unable to rigorously study it.

According to the World Health Organization, there are approximately 1.3 million new cases of breast cancer and 450,000 deaths worldwide annually. Breast cancer is the most common cancer among women. The majority of cases are sporadic, meaning there is not a family history of breast cancer, as opposed to genetic, where genes predispose a person to the disease.

Genomic Science has given the science community a opportunity to be optimistic about finding a cure. Our 1st Runner up for the person of the year is Dr. Staudt. Genomics is used in so many different ways for an example Dr. Staudt pioneered the use of gene expression profiling to discover molecularly and clinically distinct cancer subtypes and to predict response to therapy. He defined molecular subtypes of lymphoma that were previously unrecognized but are now viewed as distinct diseases that arise from different stages of B cell differentiation, utilize different oncogenic mechanisms and offer new therapeutic targets. To develop new treatments for lymphoid malignancies, Staudt’s laboratory uses various high-throughput approaches, including cancer gene resequencing, RNAi/CRISPR-based genetic screens, and combinatorial small molecule screens. The laboratory also conducts genomic investigations within therapeutic trials of targeted agents in lymphoma to define mechanisms of response and resistance.

Through The Cancer Genome Atlas (TCGA) (http://tcga.cancer.gov/), a joint effort of the National Cancer Institute and the National Human Genome Research Institute, we will greatly expand our understanding of the genetic basis of more than 20 cancers that affect adults and identify specific molecular changes that can be targeted for the development of new treatments or exploited to detect cancer earlier or prevent its occurrence.

The Top Rated Cancer Funds if you are looking for a tax deduction here is a list of Award winning organization to donate to says Barron’s Medical Journal

Breast Cancer Fund A-

Breast Cancer Research Foundation A+

Cancer Research Institute A Entertainment Industry Foundation A-

Leukemia and Lymphoma Society B+

LiveStrong Foundation A-

Memorial Sloan-Kettering Cancer Center A

Movember Foundation A

Multiple Myeloma Research Foundation A

National Breast Cancer Coalition Fund A

Ovarian Cancer Research Fund A Prevent Cancer Foundation B+

Prostate Cancer Foundation A